Hemolytic Adverse Effects of Intravenous Immunoglobulin: Modeling Predicts Risk Reduction With Anti-a/B Immunoaffinity Chromatography and to a Lesser Extent With Anti-A Donor Screening
Transfusion - United Kingdom
doi 10.1111/trf.14918
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2018
Authors
Publisher
Wiley